Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. FDA Will Have Risk-Based Import Screening System Up And Running By Year's End

This article was originally published in PharmAsia News

Executive Summary

Computer glitches have prevented implementation in all 10 U.S. FDA districts of an information technology system that flags high-risk imports for possible inspection, but the system has been effective in the four districts where it has been rolled out, Commissioner Margaret Hamburg reported to a U.S. Congressional panel April 13

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel